2026 IMS | Updated FUMANBA-1 Analysis of IASO Bio's FUCASO Reveals That In Vivo Durable Persistence of CAR-T cells Is Associated with Sustained MRD Negativity and Delayed Disease Progression

Data ReadoutpositiveEquecabtagene AutoleucelPositive

AI Analysis

Summary

IASO Bio presented updated FUMANBA-1 data on Equecabtagene Autoleucel (Fucaso) showing durable in vivo CAR-T cell persistence associated with sustained MRD negativity and delayed disease progression in a retrospective analysis of 102 patients.

Clinical Trial Data

Primary Endpoint

Met

Patients

102

Outcome Details

Updated FUMANBA-1 analysis of 102 patients demonstrates durable CAR-T cell persistence associated with sustained MRD negativity and delayed disease progression

Importance:6/10

Sentiment:

0.70

CAR-TIASO BioFUMANBA-1MRD negativitydata presentation2026 IMS

Read the original article

Published by PR Newswire Biotech on September 25, 2026 2:54 PM

Read Original